Zerona is a low-level laser device for non-invasive body slimming of the waist, hips, thighs and arms.
It has been shown to disrupt adipocyte, or fat cell, membranes causing the release of stored lipids and fatty material, in turn, promoting adipocyte collapse.
The Food and Drug Administration in 2010 indicated Zerona for use as a non-invasive dermatological aesthetic treatment for the reduction of circumference of hips, waist, thighs and arms.
Zerona was the first aesthetic device to receive this indication by the FDA.
Clinical study participants randomly assigned to receive “active” or real treatment displayed an average loss of ( 7 - 22 cm ) across the waist, hips, thighs and arms in two weeks.
Zerona is unlike other procedures as it allows the patient to continue their daily activities without interruptions from surgery, pain, wounds or garments.